- Dengue dynamics and vaccine cost-effectiveness in BrazilDavid P Durham
Yale School of Public Health, Yale University, New Haven, CT, United States
Vaccine 31:3957-61. 2013..Our results demonstrate that at the relatively low vaccine efficacy from the recent Phase 2b dengue vaccine trials, age-targeted vaccination may still be cost-effective provided the total vaccination cost is sufficiently low. ..
- Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus typesDavid P Durham
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
J Infect Dis 206:1291-8. 2012..Epidemiological data on HPV infections has been repeatedly interpreted as inconsistent with cross-immunity...